Atlas Trials

Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib

Clinical trial NCT04327700 · TERMINATED

Trial details

NCT number
NCT04327700
Sponsor
Wake Forest University Health Sciences
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2021-01-26
Primary completion
2024-05-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.